Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,271.35",
    "chg": 30.9,
    "chgp": "0.59%",
    "dir": 1,
    "prev_price": "5,240.45",
    "mcapval": "61,062.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE540L01014",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "71.52 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3920105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3920105.png",
        "date": "2026-03-27 15:00:58",
        "description": "Alkem Laboratories Ltd has witnessed a significant 43.6% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This sudden spike in open interest, coupled with volume patterns and shifting market positioning, suggests evolving investor sentiment and potential directional bets in the mid-cap pharmaceutical player."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3919872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3919872.png",
        "date": "2026-03-27 14:00:42",
        "description": "Alkem Laboratories Ltd has witnessed a significant 38.2% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3919541",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3919541.png",
        "date": "2026-03-27 13:00:26",
        "description": "Alkem Laboratories Ltd has witnessed a significant 29.4% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock underperforming its sector and broader indices. This sudden spike in open interest, coupled with volume patterns and price movements, suggests evolving market positioning and potential directional bets among traders."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3919117",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3919117.png",
        "date": "2026-03-27 12:00:12",
        "description": "Alkem Laboratories Ltd has witnessed a notable 18.14% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment for this mid-cap pharmaceutical player."
      },
      {
        "title": "Alkem Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-3918865",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_mojoScore_3918865.png",
        "date": "2026-03-27 10:10:41",
        "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916531",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3916531.png",
        "date": "2026-03-25 15:01:03",
        "description": "Alkem Laboratories Ltd has witnessed a significant 18.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a moderate 2.5% gain in the stock price, the underlying volume and open interest dynamics suggest nuanced directional bets amid a cautiously optimistic pharmaceutical sector backdrop."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3916392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3916392.png",
        "date": "2026-03-25 14:00:48",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock outperformed its sector peers with a 2.87% gain on 25 Mar 2026, supported by a 15.48% rise in open interest and robust volume patterns, reflecting evolving investor positioning ahead of upcoming catalysts."
      },
      {
        "title": "Alkem Laboratories Sees Significant Open Interest Surge Amid Bullish Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-significant-open-interest-surge-amid-bullish-derivatives-activity-3916293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3916293.png",
        "date": "2026-03-25 13:00:37",
        "description": "Alkem Laboratories Ltd has witnessed a notable 12.78% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent upgrade to a Sell rating by MarketsMOJO, the stock has outperformed its sector and broader indices over the past two days, reflecting a complex interplay of bullish and bearish sentiments among traders."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3910795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3910795.png",
        "date": "2026-03-24 15:00:44",
        "description": "Alkem Laboratories Ltd has witnessed a significant 22.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock trades below all major moving averages, reflecting underlying caution amid mixed technical and fundamental cues."
      }
    ],
    "total": 528,
    "sid": "1000019",
    "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "caption": "Please Find Attached Herewith Intimation About Increase In Investment To Be Made For Setting Up Of Manufacturing Facility Of The Company In Ujjain Madhya Pradesh.",
      "datetime": "02-Apr-2026",
      "details": "Please find attached herewith intimation about increase in investment to be made for setting up of manufacturing facility of the Company in Ujjain Madhya Pradesh.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "31-Mar-2026",
      "details": "Please find attached herewith Intimation regarding change in Senior Management.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Incorporation Of Wholly Owned Subsidiary Of The Company As A Scientific Office.",
      "datetime": "30-Mar-2026",
      "details": "Please Find Attached herewith Intimation for Incorporation of Wholly Owned Subsidiary of the Company as a Scientific Office.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-27 15:00:58

Alkem Laboratories Ltd has witnessed a significant 43.6% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This sudden spike in open interest, coupled with volume patterns and shifting market positioning, suggests evolving investor sentiment and potential directional bets in the mid-cap pharmaceutical player.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-27 14:00:42

Alkem Laboratories Ltd has witnessed a significant 38.2% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of bullish and bearish sentiments among traders.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-27 13:00:26

Alkem Laboratories Ltd has witnessed a significant 29.4% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock underperforming its sector and broader indices. This sudden spike in open interest, coupled with volume patterns and price movements, suggests evolving market positioning and potential directional bets among traders.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-27 12:00:12

Alkem Laboratories Ltd has witnessed a notable 18.14% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and shifting investor positioning, offers critical insights into potential directional bets and market sentiment for this mid-cap pharmaceutical player.

Read full news article

Alkem Laboratories Ltd is Rated Sell

2026-03-27 10:10:41

Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-25 15:01:03

Alkem Laboratories Ltd has witnessed a significant 18.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a moderate 2.5% gain in the stock price, the underlying volume and open interest dynamics suggest nuanced directional bets amid a cautiously optimistic pharmaceutical sector backdrop.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-03-25 14:00:48

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock outperformed its sector peers with a 2.87% gain on 25 Mar 2026, supported by a 15.48% rise in open interest and robust volume patterns, reflecting evolving investor positioning ahead of upcoming catalysts.

Read full news article

Alkem Laboratories Sees Significant Open Interest Surge Amid Bullish Derivatives Activity

2026-03-25 13:00:37

Alkem Laboratories Ltd has witnessed a notable 12.78% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a recent upgrade to a Sell rating by MarketsMOJO, the stock has outperformed its sector and broader indices over the past two days, reflecting a complex interplay of bullish and bearish sentiments among traders.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals

2026-03-24 15:00:44

Alkem Laboratories Ltd has witnessed a significant 22.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock trades below all major moving averages, reflecting underlying caution amid mixed technical and fundamental cues.

Read full news article

View All News